Turnstone Biologics Corp.
TSBXDelisted Aug 11, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764974
Turnstone Biologics Corp. was delisted on Aug 11, 2025; its insiders filed their last Form 4 on Aug 12, 2025; 23 institutions reported holding it in 13F filings for Q2 2025, worth $3.03M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Turnstone Biologics Corp. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +1 vs. Q3 2023
- Shares held
- 13.0M
- +816.1K (+6.7%) vs. Q3 2023
- Total value
- $33.1M
- −$14.9M (−31.1%) vs. Q3 2023
- New holders
- 3
- 13 more added
- Sold out
- 2
- 9 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TSBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 23 | $3.03M |
| Q1 2025 | 23 | $4.26M |
| Q4 2024 | 28 | $5.51M |
| Q3 2024 | 24 | $6.37M |
| Q2 2024 | 47 | $33.3M |
| Q1 2024 | 40 | $35.0M |
| Q4 2023 | 36 | $33.1M |
| Q3 2023 | 35 | $48.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Turnstone Biologics Corp.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 630 | $1.60K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 796 | $2.03K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,017 | $2.59K | 0.00% | −6,507−86.5% | Reduced |
| California State Teachers Retirement System | 1,085 | $2.76K | 0.00% | −328−23.2% | Reduced |
| Amalgamated Bank | 1,114 | $3.00K | 0.00% | −61−5.2% | Reduced |
| Wells Fargo & Company | 1,887 | $4.80K | 0.00% | +439+30.3% | Added |
| Royal Bank of Canada | 2,624 | $7.00K | 0.00% | +1,441+121.8% | Added |
| American International Group, Inc. | 3,277 | $8.34K | 0.00% | +80+2.5% | Added |
| Tower Research Capital LLC (TRC) | 3,790 | $9.65K | 0.00% | +3,311+691.2% | Added |
| JPMorgan Chase & Co | 4,222 | $10.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,171 | $18.3K | 0.00% | +5,800+423.0% | Added |
| Rhumbline Advisers | 7,241 | $18.4K | 0.00% | −589−7.5% | Reduced |
| Charles Schwab Investment Management Inc | 15,169 | $38.6K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 15,694 | $39.9K | 0.00% | +12,797+441.7% | Added |
| New York State Common Retirement Fund | 18,867 | $48.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 33,849 | $86.1K | 0.00% | +10,349+44.0% | Added |
| Caas Capital Management LP | 45,831 | $116.6K | 0.11% | −30,677−40.1% | Reduced |
| Zimmer Partners, LP | 48,200 | $122.7K | 0.00% | −93,466−66.0% | Reduced |
| Bridgeway Capital Management, LLC | 59,900 | $152.4K | 0.00% | +59,900 | New |
| Northern Trust Corp | 65,072 | $165.6K | 0.00% | +7,290+12.6% | Added |
| Barclays PLC | 116,116 | $295.5K | 0.00% | +116,116 | New |
| Geode Capital Management, LLC | 121,936 | $310.4K | 0.00% | +11,441+10.4% | Added |
| FIL Ltd | 192,657 | $490.3K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 266,853 | $679.0K | 0.01% | −53,846−16.8% | Reduced |
| Vanguard Group Inc | 296,612 | $754.9K | 0.00% | +188,003+173.1% | Added |
| BlackRock Inc. | 301,925 | $768.4K | 0.00% | +20,519+7.3% | Added |
| Sectoral Asset Management Inc | 517,648 | $1.32M | 0.57% | 00.0% | Unchanged |
| 72 Investment Holdings, LLC | 549,981 | $1.40M | 6.22% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 633,313 | $1.61M | 0.10% | −891,397−58.5% | Reduced |
| Citadel Advisors LLC | 688,468 | $1.72M | 0.00% | +1,016+0.1% | Added |
| Eventide Asset Management, LLC | 708,317 | $1.80M | 0.03% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 833,333 | $2.12M | 0.01% | 00.0% | Unchanged |
| Takeda Pharmaceutical Co Ltd | 895,824 | $2.28M | 0.70% | +895,824 | New |
| Bank of America Corp | 914,058 | $2.33M | 0.00% | +905,543+10,634.7% | Added |
| FMR LLC | 2,546,661 | $6.48M | 0.00% | −283,623−10.0% | Reduced |
| OrbiMed Advisors LLC | 3,099,265 | $7.89M | 0.16% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −43,500−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,744−100.0% | Sold out |